ClinicalTrials.gg
RecruitingNCT07858266Updated Nov 10, 2026

Deployment of a Novel National Institute of Neurological Disorders and Stroke Clinical, Biomarker, Imaging, and Modifiers (CBI-M) Classification Framework for Emergency Department Patients With Glasgow Coma Scale 15 Traumatic Brain Injury (PIONEER-Prognosis)

An observational study in Traumatic Brain Injury, sponsored by University of Michigan. Recruiting at 5 sites in United States. Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2026-11-10.

Sponsored by University of Michigan · Observational

How we know

From the registry’s dates

  • Started Oct 2026; still recruiting 1 month later.
Updated Nov 10, 2026Now RecruitingSite recruiting status changed+6 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
500
Ages
18 Years to 65 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-21

Among 10 studies in Brain Injuries, Traumatic by University of Michigan — 4 open to participants now, 5 under way, none of them phase 3. Brain Injuries, Traumatic · University of Michigan.

Started
2026
with 1 other
Observational
5 of 10
2 open now
Registered
10th of 10
by date

Among the 10 studies in Brain Injuries, Traumatic by University of Michigan, this one is one of 2 that started in 2026, is one of 5 observational ones, and was the 10th registered.

Brain Injuries, Traumatic

1,725 studies on the registry are indexed under Brain Injuries, Traumatic; 450 are open to participants now.

Browse Brain Injuries, Traumatic studies →

Open to participants now

4 of the 10 studies in Brain Injuries, Traumatic by University of Michigan are open now, in 2 countries. Recruiting first, the newest first:

By country, each count listing its studies:

All 4 open studies →

Where they have run

Who these studies take

Of the 287 Brain Injuries, Traumatic studies recruiting now, 126 (44%) set no upper age limit and 119 (41%) stop at 75 or younger; 41 take children under 18; 53 take healthy volunteers.

This study: 18 Years to 65 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 10 studies in Brain Injuries, Traumatic by University of Michigan, or all of them as a file.
02

Study summary

This study is being done to learn how information from blood tests, medical records, and wearable devices that track sleep, activity, and heart rate can help predict how people recover after a concussion. The goal is to improve how doctors monitor recovery and give patients better information about what to expect after a head injury.

Read the detailed description

The PIONEER-Prognosis Study is a prospective, multicenter, observational cohort study of adults aged 18 to 65 years who present to the emergency department (ED) within 24 hours of a mild traumatic brain injury (TBI) and have a Glasgow Coma Scale (GCS) score of 15, meaning they are fully alert. Although these injuries are classified as mild, up to half of such patients report persistent symptoms such as headaches, cognitive difficulties, and mood disturbances a year after injury, and clinicians currently lack a reliable way to predict, at the time of the ED visit, which patients will recover fully and which will not.

This study will apply a new classification framework proposed by the National Institute of Neurological Disorders and Stroke (NINDS), called Clinical, Biomarker, Imaging, and Modifiers (CBI-M). This framework combines clinical findings; blood tests for two brain injury proteins, glial fibrillary acidic protein (GFAP) and ubiquitin C-terminal hydrolase L1 (UCH-L1); results of any head computed tomography (CT) scan performed as part of routine care; and psychosocial and environmental factors. The study will evaluate how well this framework predicts recovery.

A total of 500 participants will be enrolled from five EDs in Michigan, Oregon, and California that already use GFAP and UCH-L1 blood tests in clinical care. Participants will provide a blood sample and clinical information during their ED visit, wear a WHOOP wearable device continuously for 90 days to record heart rate, heart rate variability, sleep, and physical activity, complete a brief daily symptom survey through the device application, and complete additional symptom and sleep questionnaires by email or phone at 1 week, 1 month, and 2 months.

Trained interviewers from a central outcomes team will contact participants by telephone at 14 and 90 days to assess functional recovery using the Glasgow Outcome Scale-Extended (GOS-E), along with symptoms, cognition, life satisfaction, post-traumatic stress symptoms, and resilience.

The primary outcome is complete functional recovery, defined as a GOS-E score of 8 at 90 days. The study does not assign any treatment; participants receive standard ED care. Findings are intended to improve prognostic accuracy, patient counseling, and follow-up care for the largest subgroup of patients with TBI. The prediction models developed will be made available as a free web-based tool. The study is funded by the U.S. Department of Defense and is expected to take approximately 4 years to complete, with each participant followed for 3 months.

03

Conditions studied

  • Traumatic Brain Injury

Keywords

  • traumatic brain injury
  • prognosis
  • biomarker
  • wearable
  • gfap
  • uch-l1
  • GCS 15 TBI
  • whoop
04

Who can participate

The criteria were revised on the registry on Oct 7, 2026. See what changed

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Adult patients aged 18 to 65 years at the time of enrollment who present to participating emergency departments (EDs) with suspected traumatic brain injury (TBI) meeting the 2023 American Congress of Rehabilitation Medicine (ACRM) criteria and a Glasgow Coma Scale (GCS) score of 15. Key exclusion criteria include pre-existing neurological disability resulting in a pre-injury Glasgow Outcome Scale-Extended (GOS-E) score \<8, high risk of loss to follow-up (e.g., no reliable phone, homelessness, incarceration, or ward of the state), pregnancy, and inability to speak English or Spanish

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Diagnosis of mild traumatic brain injury (TBI), as defined by the 2023 American Congress of Rehabilitation Medicine (ACRM) criteria.
  • Enrollment within 24 hours of injury.
  • Glasgow Coma Scale (GCS) score of 15 at emergency department (ED) enrollment.
  • Consent to study procedures, including:

    • Blood collection for biomarker measurement, including glial fibrillary acidic protein (GFAP) and ubiquitin C-terminal hydrolase L1 (UCH-L1).
    • Continuous use of a health-monitoring device for 3 months.
    • Follow-up assessments by telephone at 14 days and 90 days.
    • Completion of a daily symptom inventory via WHOOP/smartphone.

Exclusion criteria

Exclusion Criteria:

  • Pre-existing neurological disability or pre-injury condition that would have resulted in a Glasgow Outcome Scale-Extended (GOS-E) score \<8 if assessed before the injury.
  • High risk of loss to follow-up, including patients without a reliable phone, those experiencing homelessness, those who are incarcerated, or those who are wards of the state.
  • Pregnancy at the time of enrollment.
  • Inability to speak English or Spanish, which would prevent completion of the required assessments.
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
500 participants (estimated)
Patient registry
No
Biospecimen retention
Samples without dna

Groups and cohorts

  • GCS 15 TBI patients

    Patients presenting to a study emergency department with a Glasgow Coma Scale (GCS) score of 15 and traumatic brain injury (TBI).

06

What researchers measure

Primary outcomes

  1. Functional recovery

    Functional recovery will be assessed using the Glasgow Outcome Scale-Extended (GOS-E). The GOS-E rates patient status on one of eight levels. The minimum score is 1 and the maximum score is 8: 1 = death; 2 = vegetative state; 3 = lower severe disability; 4 = upper severe disability; 5 = lower moderate disability; 6 = upper moderate disability; 7 = lower good recovery; and 8 = upper good recovery.

    Time frame: 3 months

Secondary outcomes

  1. Daily symptom burden

    Daily symptom burden will be measured using five commonly endorsed items-fatigue, headache, poor concentration, frustration, and sleep problems-from the Rivermead Post-Concussion Questionnaire (RPQ), a validated instrument that assesses post-concussive symptom severity. Each symptom is rated from 0 to 4, with 0 indicating that the symptom is not experienced and 4 indicating a severe problem. Scores for the five items are summed to yield a total score ranging from 0 to 20, with higher scores indicating greater daily post-concussive symptom burden.

    Time frame: Up to 90 days

  2. Heart rate variability (HRV)

    HRV will be continuously measured using the WHOOP wearable device. HRV will be reported in milliseconds (ms) and reflects variation in the time intervals between successive heartbeats. HRV is a continuous physiological measure with no predefined minimum or maximum value. Higher or lower HRV values are not inherently classified as better or worse outcomes; values will be evaluated as physiological measures in relation to recovery following traumatic brain injury.

    Time frame: Up to 90 days

  3. Resting heart rate (rHR)

    Physiological outcomes will be continuously measured via the WHOOP wearable device. WHOOP is a wearable health and fitness tracker that continuously monitors key physiological metrics

    Time frame: Up to 90 days

  4. Sleep patterns - Sleep duration

    Sleep duration will be continuously measured using the WHOOP wearable device. WHOOP is a wearable health and fitness tracker that continuously monitors key physiological metrics.

    Time frame: Up to 90 days

  5. Sleep patterns - Sleep efficiency

    Sleep efficiency will be continuously measured using the WHOOP wearable device. WHOOP is a wearable health and fitness tracker that continuously monitors key physiological metrics.

    Time frame: Up to 90 days

  6. Sleep patterns - Sleep latency

    Sleep latency will be continuously measured using the WHOOP wearable device. WHOOP is a wearable health and fitness tracker that continuously monitors key physiological metrics.

    Time frame: Up to 90 days

  7. Sleep patterns - Total amount of sleep

    Total amount of sleep will be continuously measured using the WHOOP wearable device. WHOOP is a wearable health and fitness tracker that continuously monitors key physiological metrics.

    Time frame: Up to 90 days

  8. Sleep patterns - percentage of restorative sleep

    Percentage of restorative sleep will be continuously measured using the WHOOP wearable device. WHOOP is a wearable health and fitness tracker that continuously monitors key physiological metrics.

    Time frame: Up to 90 days

  9. Strain

    Strain will be continuously measured using the WHOOP wearable device. WHOOP is a wearable health and fitness tracker that continuously monitors key physiological metrics.

    Time frame: Up to 90 days

  10. Body temperature

    Body temperature will be continuously measured using the WHOOP wearable device. WHOOP is a wearable health and fitness tracker that continuously monitors key physiological metrics. ClinicalTrials.gov PRS\_ Protoco…

    Time frame: Up to 90 days

  11. Oxygen saturation

    Oxygen saturation will be continuously measured using the WHOOP wearable device. WHOOP is a wearable health and fitness tracker that continuously monitors key physiological metrics.

    Time frame: Up to 90 days

  12. Rivermead Post-Concussion Questionnaire score

    Post-concussive symptoms will be assessed using the Rivermead Post-Concussion Questionnaire (RPQ). The RPQ assesses 16 common post-concussive symptoms, with each symptom rated from 0 to 4, where 0 indicates that the symptom is not experienced, 1 indicates no more of a problem than before the injury, and 2-4 indicate mild, moderate, or severe problems, respectively. For standard scoring, responses of 1 are scored as 0, resulting in a total score ranging from 0 to 64. Higher scores indicate greater post-concussive symptom burden and therefore a worse outcome.

    Time frame: Up to 2 months

07

Study locations

3 of 5 sites recruiting
08

References and documents

Individual participant data

Plan to share: Yes — De-identified individual participant data collected during this study may be retained for future secondary analyses and will be shared in accordance with applicable U.S. Department of Defense (DoD) data-sharing policies and requirements.

Time frame: Data will be made available in accordance with applicable DoD policies and requirements.

Access criteria: Access to study data will be provided in accordance with applicable DoD policies and requirements, including any required data use agreements or other applicable protections.

No publications or documents are linked to this record.

09

Timeline

4 registry updates since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Oct 2026 (actual). Primary completion is estimated for Dec 2028, 26 months after the start.

Of 231 non-industry observational studies under Brain Injuries, Traumatic, half reached primary completion within 50 months of starting (the median), counting those still running; a quarter within 23 and three quarters within 95. This study's planned 26 months is below that.

Counting every sponsor, half of 253 studies reached it within 49 months; a quarter within 23 and three quarters within 95.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 29, 2026
First posted
Oct 5, 2026
StartActual
Oct 20, 2026
Primary completionEst.
Dec 31, 2028
CompletionEst.
Aug 30, 2029
Last update
Nov 10, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Not yet recruiting→Recruiting
changed Nov 10, 2026
Sites
1 site added, 1 site removed. 5 sites changed recruiting status (3 now recruiting, 2 now not yet recruiting)
Show 5 sites
  • Harbor-UCLA Medical Center · Torrance, United Statesno status→Not yet recruiting
  • University of Michigan · Ann Arbor, United Statesno status→Recruiting
  • Henry Ford Macomb · Clinton Township, United Statesno status→Recruiting
  • Henry Ford Hospital · Detroit, United Statesno status→Recruiting
  • Oregon Health & Science University · Portland, United Statesno status→Not yet recruiting
Show site
  • Harbor-UCLA Medical Center · Torrance, United States
Show 1 removed
  • Harbor-UCLA medical center · Torrance, United States
across 2 updates, Oct 7, 2026 – Nov 10, 2026
Eligibility
8 inclusion criteria edited; 1 exclusion criterion edited
What changed in the criteria
Inclusion criteria
  • EditedDiagnosed withDiagnosis of mild traumatic brain injury (TBI), as defined by the 2023 American Congress of Rehabilitation Medicine (ACRM) criteria.
  • EditedEnrolledEnrollment within 24 hours of injury.
  • EditedHave a Glasgow Coma Scale (GCS) score of 15 at emergency department (ED) enrollment.
  • EditedConsentedConsent to study procedures, including:
  • EditedbloodBlood collection for biomarker measurement, including glial fibrillary acidic protein (GFAP) and ubiquitin C-terminal hydrolase L1 (UCH-L1).
  • EditedwearingContinuous use of a health -monitoring device continuously for 3 months and complete:.
  • ChangedBefore A two-week and three-month follow-up assessment by telephone.Now Follow-up assessments by telephone at 14 days and 90 days.
  • EditedACompletion of a daily symptom inventory via WHOOP/smartphone.
Exclusion criteria
  • EditedPre-existing neurological disability or pre-injury condition that would have resulted in a Glasgow Outcome Scale -Extended (GOS-E) score < 8 if assessed before the injury.
Oct 7, 2026
Primary outcomes
1 description edited
What changed in the outcomes
  • DescriptionFunctional recovery: how it is measured was reworded
Oct 7, 2026
Secondary outcomes
1 edited, 10 description edited
What changed in the outcomes
  • EditedSleep patterns - Sleep efficacyefficiencyTime frame: Up to 90 days
  • DescriptionBody temperature: how it is measured was reworded
  • DescriptionDaily symptom burden: how it is measured was reworded
  • DescriptionHeart rate variability (HRV): how it is measured was reworded
  • DescriptionOxygen saturation: how it is measured was reworded
  • DescriptionRivermead Post-Concussion Questionnaire score: how it is measured was reworded
  • DescriptionSleep patterns - Sleep duration: how it is measured was reworded
  • DescriptionSleep patterns - Sleep latency: how it is measured was reworded
  • DescriptionSleep patterns - Total amount of sleep: how it is measured was reworded
  • DescriptionSleep patterns - percentage of restorative sleep: how it is measured was reworded
  • DescriptionStrain: how it is measured was reworded
Oct 7, 2026
Site contacts
Changed at 3 sites. See the sites
Show 3 sites
  • Henry Ford Macomb · Clinton Township, United StatesContact person changed (no phone or email listed)
  • Henry Ford Hospital · Detroit, United StatesContact person changed (no phone or email listed)
  • Oregon Health & Science University · Portland, United StatesContact s•••@ohsu.edu→s•••@ohsu.edu · •••2713Contact person changed (no phone or email listed)
Oct 7, 2026
Title
Deployment of a Novel NINDSNational Institute of Neurological Disorders and Stroke Clinical, Biomarker, Imaging, and Modifiers (CBI-M) Classification Framework for EDEmergency Department Patients With GCSGlasgow Coma Scale 15 TBITraumatic Brain Injury (PIONEER-Prognosis)
Oct 7, 2026
Registered
First appeared on the registry
Oct 5, 2026
Show all 4 updates
  1. Nov 10, 2026
    Not yet recruiting→Recruiting
    5 sites changed recruiting status (3 now recruiting, 2 now not yet recruiting)
    Show 5 sites
    • Harbor-UCLA Medical Center · Torrance, United Statesno status→Not yet recruiting
    • University of Michigan · Ann Arbor, United Statesno status→Recruiting
    • Henry Ford Macomb · Clinton Township, United Statesno status→Recruiting
    • Henry Ford Hospital · Detroit, United Statesno status→Recruiting
    • Oregon Health & Science University · Portland, United Statesno status→Not yet recruiting
    + 1 other change: date precision
  2. Oct 13, 2026
    Minor edits only
    + 1 other change: date precision
  3. Oct 7, 2026
    1 site added, 1 site removed
    Show site
    • Harbor-UCLA Medical Center · Torrance, United States
    Show 1 removed
    • Harbor-UCLA medical center · Torrance, United States
    Eligibility 8 inclusion criteria edited; 1 exclusion criterion edited
    What changed in the criteria
    Inclusion criteria
    • EditedDiagnosed withDiagnosis of mild traumatic brain injury (TBI), as defined by the 2023 American Congress of Rehabilitation Medicine (ACRM) criteria.
    • EditedEnrolledEnrollment within 24 hours of injury.
    • EditedHave a Glasgow Coma Scale (GCS) score of 15 at emergency department (ED) enrollment.
    • EditedConsentedConsent to study procedures, including:
    • EditedbloodBlood collection for biomarker measurement, including glial fibrillary acidic protein (GFAP) and ubiquitin C-terminal hydrolase L1 (UCH-L1).
    • EditedwearingContinuous use of a health -monitoring device continuously for 3 months and complete:.
    • ChangedBefore A two-week and three-month follow-up assessment by telephone.Now Follow-up assessments by telephone at 14 days and 90 days.
    • EditedACompletion of a daily symptom inventory via WHOOP/smartphone.
    Exclusion criteria
    • EditedPre-existing neurological disability or pre-injury condition that would have resulted in a Glasgow Outcome Scale -Extended (GOS-E) score < 8 if assessed before the injury.
    Primary outcomes 1 description edited
    What changed in the outcomes
    • DescriptionFunctional recovery: how it is measured was reworded
    Secondary outcomes 1 edited, 10 description edited
    What changed in the outcomes
    • EditedSleep patterns - Sleep efficacyefficiencyTime frame: Up to 90 days
    • DescriptionBody temperature: how it is measured was reworded
    • DescriptionDaily symptom burden: how it is measured was reworded
    • DescriptionHeart rate variability (HRV): how it is measured was reworded
    • DescriptionOxygen saturation: how it is measured was reworded
    • DescriptionRivermead Post-Concussion Questionnaire score: how it is measured was reworded
    • DescriptionSleep patterns - Sleep duration: how it is measured was reworded
    • DescriptionSleep patterns - Sleep latency: how it is measured was reworded
    • DescriptionSleep patterns - Total amount of sleep: how it is measured was reworded
    • DescriptionSleep patterns - percentage of restorative sleep: how it is measured was reworded
    • DescriptionStrain: how it is measured was reworded
    Site contacts Changed at 3 sites. See the sites
    Show 3 sites
    • Henry Ford Macomb · Clinton Township, United StatesContact person changed (no phone or email listed)
    • Henry Ford Hospital · Detroit, United StatesContact person changed (no phone or email listed)
    • Oregon Health & Science University · Portland, United StatesContact s•••@ohsu.edu→s•••@ohsu.edu · •••2713Contact person changed (no phone or email listed)
    Title Deployment of a Novel NINDSNational Institute of Neurological Disorders and Stroke Clinical, Biomarker, Imaging, and Modifiers (CBI-M) Classification Framework for EDEmergency Department Patients With GCSGlasgow Coma Scale 15 TBITraumatic Brain Injury (PIONEER-Prognosis)
    + 4 other changes: verification date, description, arm descriptions and data sharing statement
  4. Oct 5, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07858266
Collaborators
Congressionally Directed Medical Research Programs
Responsible party
Frederick Korley, MD, PhD (Professor and Executive Vice-Chair, University of Michigan) — Principal investigator
First posted
Oct 5, 2026
Start date
Oct 20, 2026
Primary completion
Dec 31, 2028 (estimated)
Completion
Aug 30, 2029 (estimated)
Last update
Nov 10, 2026

Study contacts

Devon Newman, MS
Contact
devonn@med.umich.edu
734-764-1602
Frederick Korley, MD, PhD
principal investigator · University of Michigan

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion